首页 | 本学科首页   官方微博 | 高级检索  
     

对心房颤动抗凝治疗的几点看法
引用本文:徐荣良. 对心房颤动抗凝治疗的几点看法[J]. 药学服务与研究, 2014, 0(4): 245-249
作者姓名:徐荣良
作者单位:第二军医大学长海医院心血管内科,上海200433
摘    要:心房颤动(简称房颤)是引发卒中的重要原因之一。抗凝治疗可以大大降低卒中的风险,但目前我国房颤病人接受抗凝治疗的比例很低,临床医师应该积极改善房颤病人的抗凝治疗。本文结合最新的房颤抗凝治疗指南,就如何提高房颤的知晓率、治疗率和抗凝达标率提出了一些看法和建议。

关 键 词:心房颤动  抗凝治疗  华法林  综述

Some opinions on anticoagulant therapy for patients with atrial fibrillation
XU RongLiang. Some opinions on anticoagulant therapy for patients with atrial fibrillation[J]. Pharmaceutical Care and Research, 2014, 0(4): 245-249
Authors:XU RongLiang
Affiliation:XU RongLiang(Department of Cardiovasology,Changhai Hospital, Second Military Medical University,Shanghai 200433,China)
Abstract:Atrial fibrillation is one of the primary causes of stroke, and its risk could considerably be reduced with antico- agulant therapy. However, the rate of anticoagulant therapy for atrial fibrillation patients in China is very low. Physicians should make greater efforts for the improvement of anticoagulant therapy for those affected patients. Based on the latest atrial fibrillation guidelines, the author puts forward his personal views and suggestions on how to increase the rate of knowledge, the rate of treatment and the rate of reaching a set standard concerning atrial fibrillation among atrial fibrillation patients.
Keywords:atrial fibrillation  anticoagulant therapy  warfarin  review
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号